Navigation Links
US Patent Allowed for NOD Tech

SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. announced the US Patent & Trademark Office (PTO) has allowed the patent application for its nano-particle oral delivery or NOD technology.

NOD technology is a highly efficient approach to incorporate peptides or proteins into bio-adhesive nano-particles to enable oral delivery of drugs otherwise administered as injections. NOD technology is a platform technology that can be applied to many macromolecular drugs such as insulin, interferon, growth hormone, exenatide, heparin and more.

Currently, an oral insulin formulation, the first candidate developed with NOD technology, is entering phase I clinical studies in China.

"Patent allowance for NOD technology is a major step forward for NOD", quoted from William Lee, CEO. "With this patent, and in combination with others, NOD is building a solid foundation for its intellectual property and core competence."

    For more information, please contact:

     William Lee, Ph.D., CEO
     Phone: +86-21-6194-0758

    Notes for Editors

About NOD Pharmaceuticals

NOD Pharmaceuticals, Inc. is a development stage biotech company and emerging leader in innovative delivery for biopharmaceuticals. NOD uses patented platform technology, nano-particle oral delivery or NOD technology, to develop oral formulations for biopharmaceuticals, including insulin, exenatide, interferon, human growth hormone and more.

More information can be found at .

SOURCE NOD Pharmaceuticals, Inc.

Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information
2. BioLife Solutions Granted Japanese Biopreservation Patent
3. Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
4. AvidBiotics Corp. Granted Key U.S. and European Patents on Unique Protein Modification Platform
5. Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
6. Celsis IVT Granted U.S. Patent for LiverPool(TM) Hepatocytes
7. Athera Receives Allowance of Two Key Patents
8. Jeremy M. Stipkala to Lead Symposium Entitled Patent Law Developments at SERMACS 2009
9. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
10. ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System
11. Martek Announces Settlement of Patent Dispute with Capsugel France
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier global ... it has been selected by The Michael J. Fox ... lines to academic, pharmaceutical, and biotechnology organizations committed to ... the United States , and more than ... the United States , and more than ...
(Date:10/8/2015)... Maryland , October 8, 2015 ... .   --> Goldman Small ... in the small cap and microcap sectors, announced ... research report on PharmaCyte Biotech, Inc. (OTCQB - ... focused on developing and preparing treatments for cancer ...
(Date:10/8/2015)... 8, 2015  Today, DuPont and Caribou Biosciences, ... editing, jointly announced a strategic alliance. As part ... respective patent portfolios, with DuPont receiving exclusive intellectual ... row crops, and non-exclusive rights in other agricultural ... --> --> In addition, the ...
(Date:10/8/2015)... Oct. 8, 2015  Today the Wyss Institute for ... of its start-up company Opsonix Inc. The ... Harvard,s Office of Technology Development (OTD) and Opsonix ... therapy for clinical use. --> ... a million people every year in the U.S. — ...
Breaking Biology Technology:
... Amnis Corporation announced today a,major new release ... 3.0 incorporates greatly expanded analytical capabilities,while maintaining an ... provides the user with dozens of new image ... analysis. The new software also provides the user ...
... 10 Cryo-Cell,International, Inc. (OTC Bulletin Board: CCEL) ... established family cord blood banks, today,announced results for ... Consolidated revenues for the first quarter were approximately ... $4.2,million for the first quarter of 2007. The ...
... April 10 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ... studies,of PX-478, pharmacodynamic studies of PX-12 and preclinical ... Meeting of the American Association,for Cancer Research (AACR) ... is currently conducting a Phase 1 clinical trial ...
Cached Biology Technology:
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
(Date:9/28/2015)... , Sept. 28, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced that Lenovo has selected Synaptics , ... FS4202, for its latest smartphone, the Vibe P1. The ... to unlock the device and provide swift access to ... The feature-rich Natural ID FS4202 sensor solution utilizes AES256-bit ...
(Date:9/24/2015)... 2015 Publiceringsförbud fram ... Kerv ( ), det ... världens första kontaktlösa betalningsring på i ... GBP för massproduktion via crowdfunding.  ... Kerv-bärare kan göra direkta kontaktlösa ...
Breaking Biology News(10 mins):
... Mass., May 5 Aware, Inc. (Nasdaq: AWRE ... today reported financial results for its first quarter ended March ... were $4.6 million, a decrease of 22% compared to $5.9 ... its net income and basic and diluted net income per ...
... influenza infection severity have been identified from past outbreaks. ... described in the open access journal BMC Microbiology ... Jonathan Allen and Tom Slezak from Lawrence Livermore National ... acid markers from past pandemic flu strains two weeks ...
... Ind. - Researchers at Purdue University have found a ... in searches for specific genes that shed light on ... Andrew DeWoody, a professor of genetics, and postdoctoral ... step called normalization is no longer necessary with recent ...
Cached Biology News:
Collected from 8-12 week old sexually mature rats. Pricing: $100/unit for 1 - 10 units...
... Kit is one of the most ... of RNA in solution. The ... than absorbance measurements. As little as ... fluorescence microplate readers and fluorometers using ...
... serum is extensively scrutinized, including ... All horses are of ... worming are controlled and documented ... consistency. Pricing: $12/unit ...
Biology Products: